Poor tolerability to ponatinib in Indian CML patients.
Singh C, Jain A, Lad D, Prakash G, Khadwal A, Bhurani D, Ahmed R, Agrawal N, Easow J, Varma N, Malhotra P.
Singh C, et al. Among authors: malhotra p.
Blood Adv. 2020 May 12;4(9):1927-1929. doi: 10.1182/bloodadvances.2020001944.
Blood Adv. 2020.
PMID: 32380534
Free PMC article.
No abstract available.